<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report a new observation of <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> <z:mp ids='MP_0005048'>thrombosis</z:mp> syndrome induced by a synthetic heparinoid: <z:chebi fb="0" ids="15447">pentosan</z:chebi> polysulfate and presenting with dural sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This syndrome was aggravated by standard <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> was due to an immunological mechanism and preceded thrombotic phenomena, so emphasizing the need for platelet counts in <z:hpo ids='HP_0000001'>all</z:hpo> patients considered for <z:chebi fb="5" ids="28304">heparin</z:chebi> or synthetic heparinoid therapy </plain></SENT>
</text></document>